Literature DB >> 10694644

Limb-saving surgery, survival, and prognostic factors for osteosarcoma: the Hungarian experience.

M Szendroi1, Z Pápai, R Koós, T Illés.   

Abstract

BACKGROUND AND OBJECTIVES: There are many factors thought to have an influence on the prognosis of osteosarcoma that have been reported in the literature. Their significance, however, still remains controversial in most cases. Experience with osteogenic sarcoma (OS) was reviewed in order to evaluate surgical results and survival and to determine the prognostic factors.
METHODS: Ninety-six patients with high-grade osteosarcoma of the extremities were treated between 1986 and 1997 in the authors' institution. They were divided into 3 groups: In group I, all 75 patients with nonmetastatic OS received intensive chemotherapy (high-dose methotrexate, doxorubicin, ifosfamide, and cisplatin) and underwent surgery. In group II, 9 patients already had metastases at the time of referral. In group III, 12 patients received chemotherapy in delayed or suboptimal form. Results and Conclusions In group I, there were local recurrences in 3 patients (7%) and metastases in 8 patients (20%) with limb-saving, whereas these numbers were 1 (3%) and 14 (38%) in those who had amputation. The 5-year disease-free survival (DFS) was 72% and 69% in the limb-saving and amputation groups, respectively. In groups II and III, 5-year DFS was extremely poor, 10% and 20% only, underlining the importance of stage and intensity of chemotherapy, respectively. With univariate analysis, sex, duration of symptoms, and radiographic appearance of OS had no prognostic value, whereas tumor volume <60 cm(3), wide or radical surgical margin, distal location of OS, cartilagineous ground substance <20%, and response to chemotherapy were positive prognostic factors. The last 4 variables maintained their significance in the multivariate Cox model as well. Age >30 years showed indirect negative influence on the final outcome through enhanced intolerability to the drugs and less cooperability of the patients. The results on survival with limb-saving surgery were well comparable with those of amputation. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10694644     DOI: 10.1002/(sici)1096-9098(200002)73:2<87::aid-jso6>3.0.co;2-p

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  11 in total

1.  Prognostic relevance of rosette-like features in osteosarcoma.

Authors:  K Okada; T Hasegawa; R Yokoyama; Y Beppu; E Itoi
Journal:  J Clin Pathol       Date:  2003-11       Impact factor: 3.411

2.  Study on anti-osteosarcoma activity of ethanol extract of Venenum bufonis in vitro.

Authors:  Guangxing Chen; Xuefeng Jiang; Jingyi Li; Guangjie Duan; Liu Yang; Ying Zhang; Fuyou Wang
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-11-02

3.  Long-term pulmonary function after metastasectomy for childhood osteosarcoma: a report from the St Jude lifetime cohort study.

Authors:  Jason W Denbo; Liang Zhu; DeoKumar Srivastava; Dennis C Stokes; Saumini Srinivasan; Melissa M Hudson; Kirsten K Ness; Leslie L Robison; Michael Neel; Bhaskar Rao; Fariba Navid; Andrew M Davidoff; Daniel M Green
Journal:  J Am Coll Surg       Date:  2014-03-04       Impact factor: 6.113

4.  EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.

Authors:  Naohisa Futamura; Yoshihiro Nishida; Hiroshi Urakawa; Eiji Kozawa; Kunihiro Ikuta; Shunsuke Hamada; Naoki Ishiguro
Journal:  Tumour Biol       Date:  2014-01-31

5.  Osteosarcoma: improvement in survival limited to high-grade patients only.

Authors:  Muhammad Umar Jawad; Michael C Cheung; Jennifer Clarke; Leonidas G Koniaris; Sean P Scully
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-01       Impact factor: 4.553

6.  The metastasectomy and timing of pulmonary metastases on the outcome of osteosarcoma patients.

Authors:  Yu-Min Huang; Chun-Han Hou; Sheng-Mou Hou; Rong-Sen Yang
Journal:  Clin Med Oncol       Date:  2009-09-14

Review 7.  A review of clinical and molecular prognostic factors in osteosarcoma.

Authors:  Jonathan C M Clark; Crispin R Dass; Peter F M Choong
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-27       Impact factor: 4.553

Review 8.  Update on Osteosarcoma.

Authors:  Rebekah Belayneh; Mitchell S Fourman; Sumail Bhogal; Kurt R Weiss
Journal:  Curr Oncol Rep       Date:  2021-04-21       Impact factor: 5.075

9.  Biomarker significance of plasma and tumor miR-21, miR-221, and miR-106a in osteosarcoma.

Authors:  Manjula Nakka; Wendy Allen-Rhoades; Yiting Li; Aaron J Kelly; Jianhe Shen; Aaron M Taylor; Donald A Barkauskas; Jason T Yustein; Irene L Andrulis; Jay S Wunder; Richard Gorlick; Paul S Meltzer; Ching C Lau; Tsz-Kwong Man
Journal:  Oncotarget       Date:  2017-05-27

10.  Osteosarcoma: Diagnostic dilemmas in histopathology and prognostic factors.

Authors:  Neelam Wadhwa
Journal:  Indian J Orthop       Date:  2014-05       Impact factor: 1.251

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.